Call for tenders Supplies
Anti-infectieux 2026-2030
Notice published in French. The AI analysis summarises it for you in your language.
Tenders due closed — 14 July 2026 at 10:30
- Public buyer
- HUmani SC
Charleroi - Place of performance
- 6042 Lodelinsart, Hainaut
- Planned end of contract
- 30 November 2030
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 12 June 2026
- Notice language
- French
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Le présent marché à lots a pour objet la fourniture d'anti-infectieux, dans différents dosages et formes galéniques. Ces produits seront commandés pour HUmani s.c. - CHU de Charleroi-Chimay.
49 lots
- Aciclovir injectable
- Aciclovir per os
- Amikacine injectable
- Amoxicilline per os
- Amoxicilline sirop
- Amoxicilline + acide clavulanique per os
- Amoxicilline + acide clavulanique injectable
- Amoxicilline + acide clavulanique sirop
- Anidulafungine injectable
- Atovaquone/ Proguanil
- Azithromycine per os
- Azithromycine sirop
- Benzylpenicilline G 2.000.000 et 5.000.000 UI/ml
- Caspofungine injectable
- Cefazoline injectable
- Ceftazidime injectable
- Ceftriaxone injectable
- Cefuroxime injectable
- Cefuroxime per os
- Ciprofloxacine injectable
- Ciprofloxacine per os
- Clarithromycine per os
- Clarithromycine sirop
- Clindamycine injectable
- Clindamycine per os
- Doxycycline per os
- Emtricitabine/ Tenofovir per os
- Flucloxacilline injectable
- Fluconazole per os
- Fluconazole injectable
- Itraconazole per os
- Levofloxacine per os
- Lévofloxacine injectable
- Linézolide per os
- Linézolide injectable
- Méropénem injectable
- Minocycline per os
- Moxifloxacine per os
- Moxifloxacine injectable
- Piperacilline + Tazobactam injectable
- Posaconazole per os
- Rifaximine per os
- Sulfaméthoxazole + Triméthoprime per os
- Terbinafine per os
- Tygecycline injectable
- Valaciclovir per os
- Vancomycine injectable
- Voriconazole per os
- Voriconazole injectable
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33651100 33651000 33651200 33651400
Winning prices for comparable contracts
- A quarter below
- €290,000
- Median
- €403,000
- A quarter above
- €1,351,075
Amounts awarded (excl. VAT) over the last 3 years for 5 contracts in the same CPV group (3365…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Likely competitors: who wins with this buyer in this field
- BECTON DICKINSON BENELUX · 4 contracts won
- N.V. PAUL HARTMANN S.A. · 2 contracts won
- LABORATOIRES LOHMANN & RAUSCHER s.a. · 2 contracts won
- FARLA MEDICAL · 2 contracts won
- MEDECO · 2 contracts won
Partners and subcontractors
Contract too big or too broad for you alone? Bid as a temporary consortium, or offer your services as a subcontractor.
Create your free account to see who is looking for a partner on this contract, and to register.
Companies winning this type of contract in the region
- GSK GLAXO SMITHKLINE · 1 contract won in 3 years
- PFIZER SA · 1 contract won in 3 years
Possible partners for a temporary consortium or subcontracting… and competitors worth knowing.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| VACCINS 2024-2028 HUmani SC · 19 November 2024 |
GSK GLAXO SMITHKLINE PFIZER SA |
€439,276 |
| Immunoglobuline humaine normale pour administration intraveineuse Cliniques universitaires Saint Luc · 22 October 2026 |
CSL BEHRING | €16,277,080 |
| Antimycotica AZ Delta vzw · 21 October 2026 |
Arega Pharma NV Sandoz NV Fresenius Kabi NV Pfizer NV |
€300,945 |
| Purchase, storage and delivery of live attenuated homologous vaccine against Lumpy Skin Disease European Commission, DG SANTE - Health and Food Safety · 1 October 2026 |
Huvepharma EOOD | €2,385,950 |
| Raamovereenkomst voor het leveren van immunoglobulines IV 10% Universitair Ziekenhuis Gent · 24 September 2026 |
CSL BEHRING NV | €27,360,000 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 406055-2026.